Eric Shinabarger Discusses Sharing Health Data to Fight COVID-19 in the U.S. and Canada with Lexology

Governments around the world are calling on data controllers, particularly in the healthcare and pharmaceuticals industries, to share health data in the interest of tackling COVID-19. In turn, regulators have been updating their guidance on sharing health data to help organizations balance the privacy needs of the individual with the need to collect and track health data to track infection rates and develop vaccinations.

This guidance can be challenging to navigate because while regulators in the U.S. are trying to provide companies with as much guidance as possible, their statements remain broad and open to interpretation.

As a result, compliance teams in North America are being advised to err on the side of caution when making decisions about sharing health data and be mindful that while rules may have changed in light of the current situation, they must continue to ensure the data is protected as much as possible.

Read Eric Shinabarger’s tips for navigating regulation around sharing health data in this Lexology article here.

View all of our COVID-19 perspectives here. Contact a member of our COVID-19 Legal Task Force here.